BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6622493)

  • 1. Selective release of surface antigens from cultured human melanoma cells following 1-butanol treatment.
    Liao SK; Smith JW
    Prog Clin Biol Res; 1983; 133():203-7. PubMed ID: 6622493
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.
    Liao SK; Smith JW; Kwong PC
    Cancer Immunol Immunother; 1984; 17(2):95-9. PubMed ID: 6205747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen.
    Heaney-Kieras J; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2310-6. PubMed ID: 7042082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation antigens of melanoma and melanocytes.
    Houghton AN; Cordon-Cardo C; Eisinger M
    Int Rev Exp Pathol; 1986; 28():217-48. PubMed ID: 3516910
    [No Abstract]   [Full Text] [Related]  

  • 5. Noncytolytic extraction of cell surface antigens using butanol.
    LeGrue SJ
    Cancer Metastasis Rev; 1985; 4(3):209-19. PubMed ID: 3907820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens.
    Curry RA; Quaranta V; Pellegrino MA; Ferrone S
    Cancer Res; 1981 Feb; 41(2):463-6. PubMed ID: 7448792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraction of a murine tumor-specific antigen from cells and plasma membranes using 1-butanol: augmentation of antigen yield by colchicine.
    LeGrue SJ; Kahan BD
    Cancer Res; 1985 May; 45(5):1926-9. PubMed ID: 4039219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell-surface antigen which is present in the ganglioside fraction and shared by human melanomas.
    Yeh MY; Hellström I; Abe K; Hakomori S; Hellström KE
    Int J Cancer; 1982 Mar; 29(3):269-75. PubMed ID: 7068277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiles of human melanoma-associated antigens.
    Galloway DR; Imai K; Ferrone S; Reisfeld RA
    Fed Proc; 1981 Feb; 40(2):231-6. PubMed ID: 7461145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of tumor-associated antigens shed by human melanoma cells in culture.
    Boctor AM; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2121-5. PubMed ID: 7074593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
    Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
    Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-defined human lung cell surface protein antigens.
    Mazauric T; Mitchell KF; Letchworth GJ; Koprowski H; Steplewski Z
    Cancer Res; 1982 Jan; 42(1):150-4. PubMed ID: 7053844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of morphological differentiation with enhanced surface antigen expression and susceptibility to natural killer cell lysis in theophylline-treated human melanoma cells.
    Liao SK; Kwong PC; Smith JW; Dent PB; Clark DA
    J Biol Response Mod; 1983; 2(3):280-92. PubMed ID: 6644341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.
    Steplewski Z; Chang TH; Herlyn M; Koprowski H
    Cancer Res; 1981 Jul; 41(7):2723-7. PubMed ID: 7248940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiological properties of 1-butanol-extracted cell surface antigens.
    LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
    Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.